Obscure recurrent gastrointestinal bleeding: a revealed mystery?

Maria Elena Riccioni1, Riccardo Urgesi, Rossella Cianci

  • 1Digestive Endoscopy Unit, Catholic University of Rome , Rome , Italy.

Insights

Capsule endoscopy (CE) can identify upper or lower gastrointestinal bleeding sources missed by conventional endoscopy in about 28% of obscure gastrointestinal bleeding (OGIB) cases. This highlights CE

Area of Science:

  • Gastroenterology
  • Endoscopy
  • Diagnostic Imaging

Background:

  • Capsule endoscopy (CE) is the primary diagnostic tool for obscure gastrointestinal bleeding (OGIB) after negative upper and lower gastrointestinal (GI) endoscopy.
  • A significant proportion of patients undergoing CE for OGIB have bleeding sources located in the stomach or colon, not just the small bowel.
  • Identifying missed lesions from conventional endoscopy is crucial for effective patient management in OGIB.

Purpose of the Study:

  • To determine the incidence of bleeding lesions in the upper or lower GI tract that were missed by prior gastroscopy and colonoscopy.
  • To evaluate the utility of CE in detecting these missed lesions in patients with obscure GI bleeding.
  • To assess the indications for repeating comprehensive endoscopic workup in patients with obscure bleeding before CE.

Main Methods:

  • Prospective review of data from 637 patients who underwent CE for obscure bleeding at a tertiary center.
  • All patients had previously negative gastroscopy and colonoscopy examinations.
  • Analysis focused on lesions identified by CE located outside the small bowel.

Main Results:

  • CE identified a cause of bleeding in the stomach in 21.7% (138/637) and in the colon in 6.4% (41/637) of patients with prior negative endoscopies.
  • Lesions outside the small bowel were detected in 8.5% (54/637) of patients.
  • In patients with upper/lower GI lesions, CE also frequently identified small-bowel abnormalities, and all patients received appropriate therapy.

Conclusions:

  • Approximately 28% of patients with obscure bleeding have upper or lower GI lesions missed by conventional endoscopy.
  • Capsule endoscopy plays a vital role in uncovering these missed lesions, improving diagnostic yield in OGIB.
  • CE can guide further endoscopic interventions or surgical management for non-small bowel lesions.
Abstract

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
880
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
2.4K
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant...
29
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
29
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
34
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K